title: Recurrence of dyskinesia as a side-effect of mirabegron in a patient with Parkinson's disease on DBS (GPi).
authors.affiliation: Nuffield Department of Clinical Neurosciences, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Murchison
authors.affiliation: Nuffield Department of Clinical Neurosciences, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
authors.forename: Claire
authors.initials: C
authors.lastname: Fletcher
authors.affiliation: Nuffield Department of Clinical Neurosciences, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom. Electronic address: binith.cheeran@ndcn.ox.ac.uk.
authors.forename: Binith
authors.initials: B
authors.lastname: Cheeran
mesh_terms: D000083:Acetanilides / Q000009:adverse effects*; D058667:Adrenergic beta-3 Receptor Agonists / Q000009:adverse effects*; D000368:Aged; D046690:Deep Brain Stimulation; D004409:Dyskinesia, Drug-Induced / Q000150:complications / Q000175:diagnosis*; D005260:Female; D006801:Humans; D010300:Parkinson Disease / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D012008:Recurrence; D013844:Thiazoles / Q000009:adverse effects*
chemical_list: D000083:Acetanilides; D058667:Adrenergic beta-3 Receptor Agonists; D013844:Thiazoles; C520025:mirabegron
keywords: Dyskinesia; Mirabegron; Parkinson's disease